SF3B1 and essential thrombocythemia: Some researchers reported a role of SF3B1 mutations in myelofibrotic progression in patients with polycythemia vera and essential thrombocythemia [15], whereas others concluded that SF3B1 mutations did not correlate with fibrotic evolution [16].